GF Health Products
GF Health Products, also known as Graham-Field, is a leading provider of healthcare solutions headquartered in the United States. Founded in 1943, the company has established a strong presence in the medical equipment industry, focusing on areas such as home healthcare, rehabilitation, and long-term care. With a diverse range of core products, including mobility aids, patient care equipment, and diagnostic tools, GF Health Products is recognised for its commitment to quality and innovation. The company’s unique offerings are designed to enhance patient comfort and improve healthcare outcomes. Over the years, GF Health Products has achieved significant milestones, solidifying its market position as a trusted name in healthcare. Its dedication to excellence and customer satisfaction continues to drive its success across major operational regions in North America and beyond.
DitchCarbon Score
How does GF Health Products's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GF Health Products's score of 32 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GF Health Products's reported carbon emissions
In 2023, GF Health Products reported total carbon emissions of approximately 1,382,000,000 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions accounted for about 80,000,000 kg CO2e, while Scope 2 emissions totalled approximately 134,000,000 kg CO2e (market-based). The majority of their emissions stemmed from Scope 3, which reached about 1,382,000,000 kg CO2e, highlighting significant contributions from purchased goods and services (approximately 918,000,000 kg CO2e) and the use of sold products (around 281,000,000 kg CO2e). Comparatively, emissions in 2022 were about 1,600,000,000 kg CO2e, indicating a reduction in total emissions over the year. Scope 1 emissions decreased from approximately 81,000,000 kg CO2e in 2022 to 80,000,000 kg CO2e in 2023, while Scope 2 emissions also saw a decline from about 155,000,000 kg CO2e (market-based) in 2022 to 134,000,000 kg CO2e in 2023. Despite these reductions, GF Health Products has not publicly committed to specific science-based targets or climate pledges, which may limit their long-term climate strategy. The company continues to navigate the complexities of carbon emissions across all scopes, reflecting the broader industry context of increasing accountability and transparency in climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 84,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 189,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 1,740,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GF Health Products is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
